Disclosures for "Neurophobia Experienced by Medical Students in India"
-
Ms. Eatz has nothing to disclose.
-
Mr. Kabir has nothing to disclose.
-
Mr. Ramsay has nothing to disclose.
-
The institution of Mr. Knott has received research support from American Heart Association.
-
Dr. Sanikommu has nothing to disclose.
-
An immediate family member of Mr. Fountain has received personal compensation for serving as an employee of Acumen Pharmaceuticals. An immediate family member of Mr. Fountain has received personal compensation for serving as an employee of Hexokine Therapeutics. An immediate family member of Mr. Fountain has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Acumen Pharmaceuticals. An immediate family member of Mr. Fountain has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Hexokine Therapeutics. An immediate family member of Mr. Fountain has stock in Hexokine Therapeutics. An immediate family member of Mr. Fountain has stock in Acumen Pharmaceuticals.
-
Dr. Abdelsalam has nothing to disclose.
-
Dr. Wu has nothing to disclose.
-
Robert M Starke has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medtronic. Robert M Starke has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Penumbra. The institution of Robert M Starke has received research support from NIH.
-
Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vascular Dynamics. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Guidepoint. The institution of Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GLG. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Medtronic. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Cerenovus/Johnson & Johnson. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Stryker. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving as a Consultant for Poseydon. Dr. Yavagal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Athersys. Dr. Yavagal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gravity Medical Technology. Dr. Yavagal has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Poseydon. Dr. Yavagal has stock in Poseydon. Dr. Yavagal has stock in Galaxy Therapeutics. Dr. Yavagal has stock in Stentrode. Dr. Yavagal has stock in Gravity Medical. Dr. Yavagal has stock in Gravity Medical Technology. Dr. Yavagal has stock in Athersys. Dr. Yavagal has stock in Rapid Medical . Dr. Yavagal has received intellectual property interests from a discovery or technology relating to health care. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Expert with Royal Carribean Cruise Line. Dr. Yavagal has received personal compensation in the range of $5,000-$9,999 for serving as a Medicolegal Consultant with Carnival Cruise Line.